These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1529807)

  • 21. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
    Shalaby SM; Zakora M; Otte J
    J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme inhibitors as oxygen free radical scavengers.
    Mira ML; Silva MM; Queiroz MJ; Manso CF
    Free Radic Res Commun; 1993; 19(3):173-81. PubMed ID: 8244086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury.
    Andreoli SP
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F120-7. PubMed ID: 8381600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils.
    Clapperton M; Beswick PH; Abdullah I; Dargie HJ; Fisher AC; McMurray J
    Br J Clin Pharmacol; 1995 Jul; 40(1):31-5. PubMed ID: 8527265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
    Chopra M; Beswick H; Clapperton M; Dargie HJ; Smith WE; McMurray J
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):330-40. PubMed ID: 1378110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.
    Clapperton M; McMurray J; Fisher AC; Dargie HJ
    Br J Clin Pharmacol; 1994 Jul; 38(1):53-6. PubMed ID: 7946937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ACE inhibitors on oxidation of human low density lipoprotein.
    Godfrey EG; Stewart J; Dargie HJ; Reid JL; Dominiczak M; Hamilton CA; McMurray J
    Br J Clin Pharmacol; 1994 Jan; 37(1):63-6. PubMed ID: 8148219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does luminol chemiluminescence detect free radical scavengers?
    Clapperton M; McMurray J; Fisher AC; Dargie HJ
    Br J Clin Pharmacol; 1995 Jun; 39(6):688-91. PubMed ID: 7654490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superoxide scavenging by thiol/copper complex of captopril--an EPR spectroscopy study.
    Reguli J; Misík V
    Free Radic Res; 1995 Feb; 22(2):123-30. PubMed ID: 7704183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free radical scavenging and copper chelation: a potentially beneficial action of captopril.
    Tamba M; Torreggiani A
    Free Radic Res; 2000 Mar; 32(3):199-211. PubMed ID: 10730819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus.
    Mariee AD; Al-Shabanah O
    J Pharm Biomed Anal; 2006 May; 41(2):571-5. PubMed ID: 16469467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of captopril against ischemic stress: role of cellular Mg.
    Barbagallo M; Dominguez LJ; Resnick LM
    Hypertension; 1999 Oct; 34(4 Pt 2):958-63. PubMed ID: 10523391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of copper.
    Small W; Molteni A; Kim YT; Taylor JM; Ts'ao CH; Ward WF
    Breast Cancer Res Treat; 1999 Jun; 55(3):223-9. PubMed ID: 10517167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of reactive oxygen species in the generation of fluorescence by glycation.
    Le Guen CA; Jones AF; Barnett AH; Lunec J
    Ann Clin Biochem; 1992 Mar; 29 ( Pt 2)():184-9. PubMed ID: 1320845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of captopril in invert sugar solution.
    Sam WJ; Ho PC
    J Clin Pharm Ther; 1998 Dec; 23(6):451-6. PubMed ID: 10048506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril: does it act as a direct antioxidant by free radical scavenging in humans?
    Lapenna D; Cuccurullo F
    Free Radic Biol Med; 1995 Feb; 18(2):377-9. PubMed ID: 7744323
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the fluorescence & radiation and the gamma radiation of the ionium].
    RIOUM M
    C R Hebd Seances Acad Sci; 1949 Feb; 228(8):678-80. PubMed ID: 18118510
    [No Abstract]   [Full Text] [Related]  

  • 38. Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds.
    Sadowska-Bartosz I; Galiniak S; Bartosz G
    Molecules; 2014 Apr; 19(4):4880-96. PubMed ID: 24747646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Captopril inhibits the fluorescence development associated with glycation of proteins.
    Le Guen CA; Bain S; Barnett AH; Lunec J
    Agents Actions; 1992 Jul; 36(3-4):264-70. PubMed ID: 1529807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
    Westlin W; Mullane K
    Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.